scholarly journals AYURVEDIC MANAGEMENT OF GRAHANI ROGA- CASE REPORT

2021 ◽  
Vol 9 (11) ◽  
pp. 2890-2892
Author(s):  
Aparna. T. P ◽  
Archana. S. Dachewar
Keyword(s):  
Irritable Bowel Syndrome ◽  
Case Report ◽  
Bowel Habit ◽  
Altered Bowel Habit ◽  
Irritable Bowel

Grahani Roga is a disease of Annavaha Srotas caused due to the formation of Ama due to Mandagni. Elimination of Vidagadha or Apakva anna through the Guda is known as Grahani Roga. Acharya Charaka has mentioned that the improperly digested food due to Mandagni when moved either in Urdhwa or Adho-Marga leads to Grahani Roga. Acharya Sushruta and Madhavakara have mentioned that patients of Atisara, during the stage of Agnimandya, if taken virudhha ahara, may lead to Grahani Roga. Muhur Baddha Muhur drava mala pravritti (altered bowel habit), Shleshma mala pravritti (mucous in stool) are the main symptoms of this disease. The symptoms of Grahani resemble most irritable bowel syndrome (IBS) symptoms. So, we can correlate the Grahani roga with IBS. A diagnosed case of Grahani (IBS) is discussed here who was treated with Bilwavaleha, Sanjeevani Churna, Arogyavardhini vati, Brahmi vati, Manasamitravatakam and Hingwashtak churna. Keywords: Grahani roga, IBS, Agnimandya, Case report

scholarly journals Treating irritable bowel syndrome with probiotics: the evidence

2010 ◽  
Vol 69 (2) ◽  
pp. 187-194 ◽  
Author(s):  
G. C. Parkes ◽  
J. D. Sanderson ◽  
K. Whelan
Keyword(s):  
Irritable Bowel Syndrome ◽  
Bacterial Overgrowth ◽  
Abdominal Distension ◽  
Small Intestinal Bacterial Overgrowth ◽  
Bowel Habit ◽  
Altered Bowel Habit ◽  
Small Intestinal ◽  
Irritable Bowel ◽  
Developed World ◽  
Post Infectious

Irritable bowel syndrome (IBS) is a disorder of chronic abdominal pain, altered bowel habit and abdominal distension. It is the commonest cause of referral to gastroenterologists in the developed world and yet current therapeutic strategies are often unsatisfactory. There is now increasing evidence linking alterations in the gastrointestinal (GI) microbiota and IBS. Changes in faecal and mucosa-associated microbiota, post-infectious IBS, a link with small intestinal bacterial overgrowth and an up-regulation of the GI mucosal immune system all suggest a role for the GI microbiota in the pathogenesis of IBS. Given this evidence, therapeutic alteration of the GI microbiota by probiotic bacteria could be beneficial. The present paper establishes an aetiological framework for the use of probiotics in IBS and comprehensively reviews randomised placebo-controlled trials of probiotics in IBS using multiple electronic databases. It highlights safety concerns over the use of probiotics and attempts to establish guidelines for their use in IBS in both primary and secondary care.

Intestinal microbiota fingerprint in subjects with Irritable Bowel Syndrome responders to a low FODMAP diet

2021 ◽  
Author(s):  
Fernanda Valdez-Palomares ◽  
Rafael Nambo-Venegas ◽  
Jacqueline Uribe-García ◽  
Alfredo Mendoza-Vargas ◽  
Omar Granados-Portillo ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Intestinal Microbiota ◽  
Gastrointestinal Disorder ◽  
Functional Gastrointestinal Disorder ◽  
Bowel Habit ◽  
Altered Bowel Habit ◽  
Irritable Bowel ◽  
Fodmap Diet

Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder characterized by abdominal pain and altered bowel habit. IBS patients report that FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) diet induce...

Treating drug-resistant irritable bowel syndrome with hypnosis: A case report

2019 ◽  
Vol 2 (1) ◽  
pp. 20-23
Author(s):  
Amrah Abdullayev ◽  
Zaur Orudjev
Keyword(s):  
Irritable Bowel Syndrome ◽  
Case Report ◽  
Evidence Base ◽  
Bowel Habit ◽  
Drug Resistant ◽  
Functional Disorder ◽  
Pharmacological Treatments ◽  
Limited Effect ◽  
Irritable Bowel ◽  
High Comorbidity

 Irritable Bowel Syndrome (IBS) is a functional disorder of gastrointestinal system, characterized by abdominal pain, bowel habit change, bloating and etc. Pharmacological treatments usually have limited effect on IBS. IBShas high comorbidity with mood and anxiety disorders which are seems related to bowel symptoms . Treatment choices for managing IBS are pharmacological, dietary, lifestyle change, physical activity and psychotherapy. Effectiveness of psychotherapeutic procedures for IBS was demonstrated before. In this case report, patient with resistant IBS,  gone under hypnotherapy and this trial serves as little contribution to the evidence base for the treatment of IBS by applying psychological approach.

Irritable bowel syndrome

2019 ◽  
Vol 12 (9) ◽  
pp. 497-500
Author(s):  
Matthew Sutcliffe
Keyword(s):  
Primary Care ◽  
Irritable Bowel Syndrome ◽  
Abdominal Discomfort ◽  
Bowel Habit ◽  
Gastrointestinal Disorders ◽  
Functional Bowel Disorder ◽  
Delay In Diagnosis ◽  
Altered Bowel Habit ◽  
Irritable Bowel

Irritable bowel syndrome (IBS) is a functional bowel disorder that commonly presents in primary care and has an array of symptoms including abdominal discomfort and altered bowel habit. There may be an overlap of symptoms with other gastrointestinal disorders, leading to difficulty or delay in diagnosis. The condition can produce a variety of troublesome physical and psychological sequelae causing significant impact on an individual’s quality of life. The aim of this article is to highlight the ways in which IBS can present to the General Practitioner and guide the approach to investigation, diagnosis and management in primary care.

Irritable bowel syndrome

2020 ◽  
pp. 2951-2959
Author(s):  
Adam D. Farmer ◽  
Qasim Aziz
Keyword(s):  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Recurrent Abdominal Pain ◽  
Bowel Habit ◽  
Western World ◽  
Older Individuals ◽  
Butyl Bromide ◽  
Rome Iii ◽  
Fermentable Carbohydrates ◽  
Irritable Bowel

Symptoms suggestive of disturbed lower gastrointestinal function without adequate explanation are very common in adults in the Western world, up to 15% of whom experience such symptoms at any one time, although most do not seek medical advice. The currently used terms are best viewed as an attempt to provide some clinically useful, rather than pathophysiologically accurate, categorization of patients and their symptoms based on disordered gut–brain interactions. Irritable bowel syndrome is defined according to the Rome III criteria as recurrent abdominal pain or discomfort associated with a change in bowel habit for at least 6 months, with symptoms experienced on at least 3 days of at least 3 months. Many subtypes are recognized. Routine haematological and biochemical screening is usually performed on the assumption that it will be normal. Features that raise the suspicion of organic disease and indicate a need for further investigation include the onset of symptoms in middle-aged or older individuals, weight loss, or blood in the stool. Management remains empirical: no single pharmacological agent or group of agents has ever been found to be consistently effective. The principal task of the physician is to provide explanation and reassurance (sometimes supplemented by psychological treatments), but particular symptoms are often treated as follows: (1) constipation—defecation may be eased by supplementary dietary fibre and poorly absorbed fermentable carbohydrates which increase faecal bulk and soften the stool; osmotic laxatives and enemas are used for the severely constipated patient, as well as more novel agents; (2) diarrhoea—attention to diet is often helpful, as are simple antidiarrhoeal agents; and (3) abdominal pain—antispasmodics (e.g. hyoscine butyl bromide) are frequently used, as are antidepressants.

Some antispasmodic drugs for the irritable bowel syndrome

1986 ◽  
Vol 24 (24) ◽  
pp. 93-95
Keyword(s):  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Intestinal Disease ◽  
Bowel Habit ◽  
Dietary Advice ◽  
Irritable Bowel

Irritable bowel syndrome (IBS) is commonly diagnosed when the typical symptoms of irregular bowel habit, abdominal pain and distension, and a feeling of incomplete defaecation are not associated with other gastro-intestinal disease. The management of the patient with IBS has been covered previously1 but if dietary advice, reassurance and simple psychotherapy have proved unhelpful the doctor may be under pressure to prescribe as symptoms are usually recurrent. We now review the evidence to support the use of some antispasmodic drugs.

scholarly journals Tu1894 – Colonic Mucosal Microbiome is Associated with Bowel Habit Subtypes in Irritable Bowel Syndrome (IBS) Patients

2019 ◽  
Vol 156 (6) ◽  
pp. S-1163-S-1164
Author(s):  
Swapna Mahurkar-Joshi ◽  
Jonathan P. Jacobs ◽  
Venu Lagishetty ◽  
Charlene Choo ◽  
Emeran A. Mayer ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Bowel Habit ◽  
Irritable Bowel

scholarly journals Irritable Bowel Syndrome: More Than Abdominal Pain and Bowel Habit Abnormalities

2009 ◽  
Vol 7 (1) ◽  
pp. 73-79 ◽  
Author(s):  
Brian Bond ◽  
Judith Quinlan ◽  
George E. Dukes ◽  
Fermin Mearin ◽  
Ray E. Clouse ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Bowel Habit ◽  
Irritable Bowel
Sign in / Sign up

Export Citation Format

Share Document